Build an AI Oncology Clinical-Trial Patient-Matching System

1. 1

   Attack the chart-review bottleneck directly

   The problem is concrete: cancer-trial enrollment reaches only 5 to 7 percent of adult patients, largely because matching patients to trials means slow manual chart review. As context, one validated hospital deployment screened 98,348 patients across 29 trials and reduced chart-review workload tenfold. Automating that review is the entire value proposition and why this is a distinct product.

2. 2

   Build NLP over clinical records

   The system uses natural-language processing and structured-data models to read patient records and extract the criteria that determine trial eligibility. Accuracy on messy, unstructured clinical text is the core technical challenge. False negatives (missed eligible patients) and false positives both matter.

3. 3

   Encode and match against trial criteria

   Trial eligibility criteria are complex and change, so the system must encode them and match patients against many trials at once. Keeping criteria current and matching precisely is ongoing work. This matching logic is where the tenfold efficiency gains come from.

4. 4

   Integrate with hospital data systems

   The tool must connect to EHRs and hospital data under strict privacy and data-use agreements to screen real patient populations. Integration and governance are prerequisites to any deployment. Clean, compliant data access is the practical gate to value.

5. 5

   Validate and prove the workload reduction

   Buyers care about measurable outcomes: more eligible patients found, faster, with less staff time, as the validated deployment demonstrated. Prove the efficiency and enrollment gains in real settings. Evidence of workload reduction is what closes sales.

6. 6

   Sell to sponsors, sites, and networks

   Customers are trial sponsors, hospitals, and research sites who all benefit from faster enrollment, and funding often comes from the sponsors who need patients. Define the buyer and pricing clearly. The broader enrollment-bottleneck opportunity is captured as its own adjacency card alongside this product.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: NLP and health-data founders targeting clinical-trial operations

Not for: Anyone who underestimates eligibility-criteria complexity or hospital data integration. The value is operational leverage on a real bottleneck, and it demands validation, integration, and compliance rigor. Nothing here is medical advice.